This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report From the Bacterial Keratitis Study Research Group

Terrence P. O'Brien, MD; Maureen G. Maguire, PhD; Nancy E. Fink, MPH; Eduardo Alfonso, MD; Peter McDonnell, MD; Bacterial Keratitis Study Research Group

Arch Ophthalmol. 1995;113(10):1257-1265.

Abstract
Purpose
To compare ofloxacin solution with a combination of fortified antibiotic cefazolin sodium and tobramycin sulfate solutions in the treatment of bacterial keratitis.

Methods
Patients under care at any one of 28 participating clinical centers who had an eye with suspected bacterial keratitis were randomly allocated in a double-masked manner to treatment with 0.3% ofloxacin solution or a combination of the fortified antibiotics (1.5% tobramycin and 10.0% cefazolin solutions).

Main Outcome Measures
Time to healing defined as complete re-epithelization, accompanied by a nonprogressive stromal infiltrate for two consecutive visits. Secondary outcome measures included patient symptoms and signs of infection and adverse reactions to study medications. Only patients with a positive bacterial corneal culture were included in most analyses.

Results
A positive bacterial corneal culture was obtained in 140 (56%) of the 248 enrolled patients. The time to healing was similar among the 73 patients receiving ofloxacin and the 67 patients receiving fortified antibiotics (P=.70). By 7 days after study entry, the keratitis in 37% of the ofloxacin group and 38% of the fortified antibiotics group had healed. By 28 days, keratitis in 89% of the ofloxacin group and 86% of the fortified antibiotics group had healed. Two patients receiving ofloxacin and one receiving fortified antibiotics discontinued study medication because of lack of efficacy. Patients receiving ofloxacin reported substantially less burning and stinging on instillation than the patients receiving fortified antibiotics (P<.001). Five of six patients among the 140 with positive bacterial cultures who had study medications discontinued because of ocular side effects were in the fortified antibiotics group; an additional three patients, all in the fortified antibiotics group, among the remaining 108 receiving study medications had ocular side effects.

Conclusions
The efficacy of ofloxacin solution in treating bacterial keratitis is equivalent to that of the fortified cefazolin and tobramycin solutions. The reduced frequency of ocular toxic effects and the relative ease of preparation of ofloxacin are additional considerations.

Footnotes
A complete list of the members of the Bacterial Keratitis Study Research Group appears on page 1264. Members of the writing team have no financial or proprietary interest in any of the compounds investigated in this study.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Corticosteroids for bacterial corneal ulcers
Srinivasan et al.
Br J Ophthalmol 2009;93:198-202.
ABSTRACT | FULL TEXT  

Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis
Choy et al.
J Med Microbiol 2008;57:1539-1546.
ABSTRACT | FULL TEXT  

Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones
Yamada et al.
Br J Ophthalmol 2008;92:848-851.
ABSTRACT | FULL TEXT  

Ocular Pathogen or Commensal: A PCR-Based Study of Surface Bacterial Flora in Normal and Dry Eyes
Graham et al.
IOVS 2007;48:5616-5623.
ABSTRACT | FULL TEXT  

Risk factors for perforation in microbial corneal ulcers in north India
Titiyal et al.
Br J Ophthalmol 2006;90:686-689.
ABSTRACT | FULL TEXT  

Treatment of Experimental Bacterial Keratitis With Topical Trovafloxacin
Barequet et al.
Arch Ophthalmol 2004;122:65-69.
ABSTRACT | FULL TEXT  

The efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulceration
Bosscha et al.
Br J Ophthalmol 2004;88:25-28.
ABSTRACT | FULL TEXT  

A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis
Prajna et al.
Br J Ophthalmol 2003;87:1235-1237.
ABSTRACT | FULL TEXT  

View 2: Empirical fluoroquinolone therapy is sufficient initial treatment
Morlet and Daniell
Br J Ophthalmol 2003;87:1169-1172.
FULL TEXT  

Overview: Initial antimicrobial therapy for microbial keratitis
Daniell
Br J Ophthalmol 2003;87:1172-1174.
FULL TEXT  

View 1: Corneal scraping and combination antibiotic therapy is indicated
Mills
Br J Ophthalmol 2003;87:1167-1169.
FULL TEXT  

Simplifying Collection of Corneal Specimens in Cases of Suspected Bacterial Keratitis
Kaye et al.
J. Clin. Microbiol. 2003;41:3192-3197.
ABSTRACT | FULL TEXT  

Microbial keratitis
Jeng and McLeod
Br J Ophthalmol 2003;87:805-806.
FULL TEXT  

Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases
Bourcier et al.
Br J Ophthalmol 2003;87:834-838.
ABSTRACT | FULL TEXT  

Emergence of Refractive Surgery
McDonnell
Arch Ophthalmol 2000;118:1119-1120.
FULL TEXT  

In vitro antibiotic resistance in bacterial keratitis in London
Tuft and Matheson
Br J Ophthalmol 2000;84:687-691.
ABSTRACT | FULL TEXT  

Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers
Gangopadhyay et al.
Br J Ophthalmol 2000;84:378-384.
ABSTRACT | FULL TEXT  

Molecular Characterization and Antibiotic Susceptibilities of Ocular Isolates of Staphylococcus epidermidis
Sechi et al.
J. Clin. Microbiol. 1999;37:3031-3033.
ABSTRACT | FULL TEXT  

Risk factors for treatment outcome of suspected microbial keratitis
Morlet et al.
Br J Ophthalmol 1999;83:1027-1031.
ABSTRACT | FULL TEXT  

Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections
Pinna et al.
Br J Ophthalmol 1999;83:771-773.
ABSTRACT | FULL TEXT  

16S Ribosomal DNA Typing for Identification of Pathogens in Patients with Bacterial Keratitis
Knox et al.
J. Clin. Microbiol. 1998;36:3492-3496.
ABSTRACT | FULL TEXT  

Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers
Bennett et al.
Br J Ophthalmol 1998;82:137-145.
ABSTRACT | FULL TEXT  

Intracorneal, Aqueous Humor, and Vitreous Humor Penetration of Topical and Oral Ofloxacin
Donnenfeld et al.
Arch Ophthalmol 1997;115:173-176.
ABSTRACT  

Efficacy of Ofloxacin vs Cefazolin and Tobramycin in the Therapy for Bacterial Keratitis
Baker et al.
Arch Ophthalmol 1996;114:632-632.
ABSTRACT  

Empirical or Culture-Guided Therapy for Microbial Keratitis? A Plea for Data
McDonnell
Arch Ophthalmol 1996;114:84-87.
ABSTRACT